Light‐Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells

The design, synthesis, photochemical properties, and biological evaluation of a novel photoactivatable bichromophoric conjugate are reported. The compound 1, [4‐(4,4‐difluoro‐2,6‐diiodo‐1,3,5,7‐tetramethyl‐4‐bora‐3a,4a‐diaza‐s‐indacen‐8‐yl)‐N‐(3‐((4‐nitro‐3‐(trifluoromethyl)phenyl)amino)propyl)butanamide] combines a 2,6‐diiodo‐1,3,5,7‐tetramethyl BODIPY derivative as singlet oxygen (1O2) photosensitizer and 4‐nitro‐3‐(trifluoromethyl)aniline (NOPD) as nitric oxide (NO) photodonor, joined by an alkyl spacer. These two chromogenic units absorb in distinct regions of the visible spectrum, and their individual photochemical properties are conserved in the molecular conjugate. Irradiation of the bichromophoric conjugate with green light afforded 1O2 in high quantum yields, whereas 1O2 production was negligible with the use of blue light; under this latter condition, NO was released. Photogeneration of NO and cytotoxic 1O2 can therefore be regulated by appropriately tuning the excitation light wavelength and intensity. Tested on melanoma cancer cells, this resulted in amplified photomortality relative to that of a structurally correlated model compound 2 [4‐(4,4‐difluoro‐2,6‐diiodo‐1,3,5,7‐tetramethyl‐4‐bora‐3a,4a‐diaza‐s‐indacen‐8‐yl)‐N‐(3‐(p‐tolylamino)propyl)butanamide] deprived of the NO‐release capacity. The cellular uptake of 1, evaluated by confocal fluorescence microscopy, showed that the product is localized in the cytoplasm.

[1]  Patrycja Nowak-Sliwinska,et al.  In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. , 2010, Journal of medicinal chemistry.

[2]  V. Cardile,et al.  Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas. , 2013, Acta histochemica.

[3]  D. Nowis,et al.  Light and Light Sources for Pdt Direct Tumor Damage Mechanisms of Photodynamic Therapy , 2005 .

[4]  Shaomin Ji,et al.  Organic triplet sensitizer library derived from a single chromophore (BODIPY) with long-lived triplet excited state for triplet-triplet annihilation based upconversion. , 2011, The Journal of organic chemistry.

[5]  V. Cardile,et al.  An engineered nanoplatform for bimodal anticancer phototherapy with dual-color fluorescence detection of sensitizers. , 2013, Chemical communications.

[6]  P. Mascharak,et al.  Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. , 2011, Accounts of chemical research.

[7]  Kevin Burgess,et al.  BODIPY dyes and their derivatives: syntheses and spectroscopic properties. , 2007, Chemical reviews.

[8]  R. Parenti,et al.  Wilms’ Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line , 2014, PloS one.

[9]  Shiguo Sun,et al.  Carboxyl BODIPY dyes from bicarboxylic anhydrides: one-pot preparation, spectral properties, photostability, and biolabeling. , 2009, The Journal of organic chemistry.

[10]  S. Sortino Light-controlled nitric oxide delivering molecular assemblies. , 2010, Chemical Society reviews.

[11]  S. Monti,et al.  Supramolecular photochemistry of drugs in biomolecular environments. , 2014, Chemical Society reviews.

[12]  B. Wilson,et al.  The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.

[13]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.

[14]  S. Wimalawansa Nitric oxide: new evidence for novel therapeutic indications , 2008 .

[15]  S. Huerta,et al.  Nitric oxide donors: novel cancer therapeutics (review). , 1992 .

[16]  L. Arnaut,et al.  Photodynamic therapy (PDT) of cancer: from local to systemic treatment , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[17]  J. Lancaster,et al.  Nitric oxide: a new paradigm for second messengers. , 1995, Journal of medicinal chemistry.

[18]  A. W. Carpenter,et al.  Nitric oxide release: part II. Therapeutic applications. , 2012, Chemical Society reviews.

[19]  M. Biel Photodynamic therapy of bacterial and fungal biofilm infections. , 2010, Methods in molecular biology.

[20]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[21]  B. Krammer,et al.  Vascular effects of photodynamic therapy. , 2001, Anticancer research.

[22]  D. Wink,et al.  The biphasic nature of nitric oxide responses in tumor biology. , 2006, Antioxidants & redox signaling.

[23]  Michael R Hamblin,et al.  Photodynamic therapy: a new antimicrobial approach to infectious disease? , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[24]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.

[25]  S. Sortino,et al.  Two-photon fluorescence imaging and bimodal phototherapy of epidermal cancer cells with biocompatible self-assembled polymer nanoparticles. , 2014, Biomacromolecules.

[26]  Youngjae You,et al.  Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy , 2012 .

[27]  Paul Baas,et al.  Photodynamic therapy in oncology. , 2006, The oncologist.

[28]  Harold S. Freeman,et al.  Dye Sensitizers for Photodynamic Therapy , 2013, Materials.

[29]  P. Ford Photochemical delivery of nitric oxide. , 2013, Nitric oxide : biology and chemistry.

[30]  R Lecomte,et al.  Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment , 2009, British Journal of Cancer.

[31]  John F. Callan,et al.  Carbon quantum dot-NO photoreleaser nanohybrids for two-photon phototherapy of hypoxic tumors. , 2015, Chemical communications.

[32]  C. Ratanatawanate,et al.  S-nitrosocysteine-decorated PbS QDs/TiO2 nanotubes for enhanced production of singlet oxygen. , 2011, Journal of the American Chemical Society.

[33]  A. Noronha-Dutra,et al.  Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide‐mediated killing , 1993, FEBS letters.

[34]  Takayoshi Suzuki,et al.  Visible light-induced nitric oxide release from a novel nitrobenzene derivative cross-conjugated with a coumarin fluorophore. , 2014, Bioorganic & medicinal chemistry letters.

[35]  Takayoshi Suzuki,et al.  Photoinduced nitric oxide release from nitrobenzene derivatives. , 2005, Journal of the American Chemical Society.

[36]  R. E. Kellogg,et al.  Radiationless Intermolecular Energy Transfer. III. Determination of Phosphorescence Efficiencies , 1964 .

[37]  Frank Verhaegen,et al.  Spectroscopic characterization of a novel electronic brachytherapy system , 2008, Physics in medicine and biology.

[38]  Ming Xian,et al.  Nitric oxide donors: chemical activities and biological applications. , 2002, Chemical reviews.

[39]  P. Ford Polychromophoric metal complexes for generating the bioregulatory agent nitric oxide by single- and two-photon excitation. , 2008, Accounts of chemical research.

[40]  S. Sortino,et al.  Amplified nitric oxide photorelease in DNA proximity. , 2008, Chemical communications.

[41]  K. Ghiggino,et al.  Singlet oxygen quantum yields of potential porphyrin-based photosensitisers for photodynamic therapy , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[42]  V. Ponomarev,et al.  Mechanism of cell death mediated by a BF2‐chelated tetraaryl‐azadipyrromethene photodynamic therapeutic: Dissection of the apoptotic pathway in vitro and in vivo , 2012, International journal of cancer.

[43]  L. Arnaut,et al.  Modulation of Biodistribution, Pharmacokinetics, and Photosensitivity with the Delivery Vehicle of a Bacteriochlorin Photosensitizer for Photodynamic Therapy , 2014, ChemMedChem.

[44]  S. Petralia,et al.  Photodelivery of nitric oxide from water-soluble platinum nanoparticles. , 2007, Journal of the American Chemical Society.

[45]  V. Cardile,et al.  A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells , 2014 .

[46]  T. Parisi,et al.  A cyclodextrin-based nanoassembly with bimodal photodynamic action. , 2012, Chemistry.

[47]  K. Burgess,et al.  BODIPY dyes in photodynamic therapy. , 2013, Chemical Society reviews.

[48]  I. Perillo,et al.  Selective Monoformylation Of 1,3-Diaminopropane Derivatives , 1999 .

[49]  Y. Urano,et al.  Highly efficient and photostable photosensitizer based on BODIPY chromophore. , 2005, Journal of the American Chemical Society.

[50]  S. Gibson,et al.  Current clinical and preclinical photosensitizers for use in photodynamic therapy. , 2004, Journal of medicinal chemistry.

[51]  P. Wang,et al.  Recent developments in anticancer nitric oxide donors , 2004 .

[52]  C. Brett,et al.  Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers. , 2014, Chemistry.

[53]  K. Yeung,et al.  Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. , 2008, Nitric oxide : biology and chemistry.

[54]  Jason R. Hickok,et al.  Nitric oxide and cancer therapy: the emperor has NO clothes. , 2010, Current pharmaceutical design.

[55]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[56]  T. Maisch A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment. , 2009, Mini reviews in medicinal chemistry.

[57]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.

[58]  J. Lehmann Nitric oxide donors - current trends in therapeutic applications , 2000 .

[59]  N. Hogg,et al.  Cancer cell metabolism and the modulating effects of nitric oxide. , 2015, Free radical biology & medicine.

[60]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.